Gopa Iyer

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

Katherine A. Hoadley, Jen Jen Yeh, Jeffrey S. Damrauer, 2014, Proceedings of the National Academy of Sciences.

Convergent loss of PTEN leads to clinical resistance to a PI3Kα inhibitor

Obi L. Griffith, Malachi Griffith, Benjamin J. Ainscough, 2014, Nature.

BRAF Mutation is associated with early stage disease and improved outcome in patients with low‐grade serous ovarian cancer

Alexia Iasonos, Deborah DeLair, Qin Zhou, 2013, Cancer.

Comparison of genomic alterations in bladder urothelial tumors with and without telomerase reverse transcriptase promoter mutation using a next-generation sequencing assay.

Ahmet Zehir, Michael F. Berger, David B. Solit, 2017 .

New Molecular Markers with Diagnostic and Prognostic Values in Bladder Cancer

Hikmat Al-Ahmadie, G. Iyer, H. Al-Ahmadie, 2015 .

Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.

Kenneth Offit, Barry S Taylor, Vignesh Ravichandran, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer

Qiang Li, Joaquim Bellmunt, Nadeem Riaz, 2018, Clinical Cancer Research.